Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- Check3 days agoChange DetectedRecruitment status now shows closure for participants, and additional help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The revision note was updated to v3.6.0 and a related heading change was made.SummaryDifference0.5%

- Check11 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This update is a maintenance/versioning change and does not alter the trial details or data presented on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This appears to be a minor site/build update with no substantive changes to the study details or navigation.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision label was updated from v3.5.2 to v3.5.3, signaling a small release update without modifying the study details.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision metadata updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0. This appears to be a minor version update with no substantive changes to the study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.